Our data, showing that epigenetic inactivation of BMP3b (at a frequency similar to that previously reported (Dai et al, 2004)) and BMP6 tend to occur together in lung cancer, suggests that in NSCLC multiple BMPs may need to be silenced in order to abrogate their antigrowth signalling. The gene discussed is CLN5; the disease is lung cancer.